| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
185,611,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
6,246,627 |
Avg
Vol: |
2,847,643 |
| 52
Week Range: |
$23.99 - $23.99 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Berger Harvey J MD |
Chairman & CEO |
• • – |
2014-03-19 |
4 |
D |
$8.19 |
$95,913 |
D/D |
(11,711) |
1,075,048 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2014-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,000 |
1,086,759 |
|
- |
|
| Cantor Maria E |
SVP, Corporate Affairs and HR |
• • – |
2014-03-19 |
4 |
D |
$8.19 |
$16,880 |
D/D |
(2,061) |
78,713 |
|
- |
|
| Cantor Maria E |
SVP, Corporate Affairs and HR |
• • – |
2014-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
80,774 |
|
- |
|
| Haluska Frank |
SVP, Clinical R&D, CMO |
• • – |
2014-03-19 |
4 |
D |
$8.19 |
$16,880 |
D/D |
(2,061) |
95,596 |
|
- |
|
| Haluska Frank |
SVP, Clinical R&D, CMO |
• • – |
2014-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
97,657 |
|
- |
|
| Berstein David L |
SVP, GC and Chief IP Officer |
• • – |
2014-03-19 |
4 |
D |
$8.19 |
$12,334 |
D/D |
(1,506) |
224,642 |
|
- |
|
| Berstein David L |
SVP, GC and Chief IP Officer |
• • – |
2014-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,750 |
226,148 |
|
- |
|
| Bollag Daniel M |
Sr. VP, Reg. Affairs & Quality |
• • – |
2014-03-19 |
4 |
D |
$8.19 |
$20,770 |
D/D |
(2,536) |
140,863 |
|
- |
|
| Bollag Daniel M |
Sr. VP, Reg. Affairs & Quality |
• • – |
2014-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
143,399 |
|
- |
|
| Fitzgerald Edward M |
Executive VP, CFO |
• • – |
2014-03-19 |
4 |
D |
$8.19 |
$28,133 |
D/D |
(3,435) |
255,940 |
|
- |
|
| Fitzgerald Edward M |
Executive VP, CFO |
• • – |
2014-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,834 |
259,375 |
|
- |
|
| Duvall Martin J |
EVP, CCO |
• • – |
2014-03-19 |
4 |
D |
$8.19 |
$21,441 |
D/D |
(2,618) |
29,203 |
|
- |
|
| Duvall Martin J |
EVP, CCO |
• • – |
2014-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
31,821 |
|
- |
|
| Denner Alexander J |
Director |
– • – |
2014-02-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,000,000 |
|
- |
|
| Lamarche Jay R |
Director |
• • – |
2014-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
427,205 |
|
- |
|
| Whelan Jr. Robert M. |
Director |
• • – |
2014-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
44,859 |
|
- |
|
| Schlesinger Sarah J. |
Director |
• • – |
2014-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
|
- |
|
| Riedel Norbert G |
Director |
• • – |
2014-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
96,859 |
|
- |
|
| Wilson Wayne |
Director |
• • – |
2014-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
100,500 |
|
- |
|
| Lavidas Athanese |
Director |
• • – |
2014-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
106,631 |
|
- |
|
| Radaelli Massimo |
Director |
• • – |
2014-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
80,500 |
|
- |
|
| Cantor Maria E |
SVP, Corporate Affairs |
• • – |
2013-12-19 |
4 |
AS |
$5.14 |
$32,768 |
D/D |
(6,375) |
74,274 |
|
- |
|
| Berstein David L |
Senior VP, Chief IP Officer |
• • – |
2013-12-19 |
4 |
AS |
$5.14 |
$23,130 |
D/D |
(4,500) |
221,398 |
|
- |
|
| Clackson Timothy P |
President, R&D, CSO |
• • – |
2013-12-19 |
4 |
AS |
$5.14 |
$50,115 |
D/D |
(9,750) |
380,319 |
|
- |
|
703 Records found
|
|
Page 11 of 29 |
|
|
